LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 4 of total 4

Search options

  1. Article ; Online: Detection of SARS-CoV-2 RNA in serum is associated with increased mortality risk in hospitalized COVID-19 patients.

    Rodríguez-Serrano, Diego A / Roy-Vallejo, Emilia / Zurita Cruz, Nelly D / Martín Ramírez, Alexandra / Rodríguez-García, Sebastián C / Arevalillo-Fernández, Nuria / Galván-Román, José María / Fontán García-Rodrigo, Leticia / Vega-Piris, Lorena / Chicot Llano, Marta / Arribas Méndez, David / González de Marcos, Begoña / Hernando Santos, Julia / Sánchez Azofra, Ana / Ávalos Pérez-Urria, Elena / Rodriguez-Cortes, Pablo / Esparcia, Laura / Marcos-Jimenez, Ana / Sánchez-Alonso, Santiago /
    Llorente, Irene / Soriano, Joan / Suárez Fernández, Carmen / García-Vicuña, Rosario / Ancochea, Julio / Sanz, Jesús / Muñoz-Calleja, Cecilia / de la Cámara, Rafael / Canabal Berlanga, Alfonso / González-Álvaro, Isidoro / Cardeñoso, Laura

    Scientific reports

    2021  Volume 11, Issue 1, Page(s) 13134

    Abstract: ... at risk of poor outcomes is critical. Our objective was to analyse SARS-CoV-2 RNA detection in serum ... 19. Detection of SARS-CoV-2 RNA in serum (viremia) was performed with samples collected at 48-72 h ... mortality and need for ICU admission during hospitalization for COVID-19. Viremia was detected in 50-60 ...

    Abstract COVID-19 has overloaded national health services worldwide. Thus, early identification of patients at risk of poor outcomes is critical. Our objective was to analyse SARS-CoV-2 RNA detection in serum as a severity biomarker in COVID-19. Retrospective observational study including 193 patients admitted for COVID-19. Detection of SARS-CoV-2 RNA in serum (viremia) was performed with samples collected at 48-72 h of admission by two techniques from Roche and Thermo Fischer Scientific (TFS). Main outcome variables were mortality and need for ICU admission during hospitalization for COVID-19. Viremia was detected in 50-60% of patients depending on technique. The correlation of Ct in serum between both techniques was good (intraclass correlation coefficient: 0.612; p < 0.001). Patients with viremia were older (p = 0.006), had poorer baseline oxygenation (PaO
    MeSH term(s) Aged ; Biomarkers/blood ; COVID-19/blood ; COVID-19/mortality ; COVID-19/virology ; Critical Care ; Female ; Hospitalization ; Humans ; Interleukin-6/blood ; Male ; Middle Aged ; Patient Acuity ; RNA, Viral/blood ; Real-Time Polymerase Chain Reaction ; Retrospective Studies ; Risk Factors ; SARS-CoV-2/genetics ; Spain ; Viremia/blood ; Viremia/virology
    Chemical Substances Biomarkers ; Interleukin-6 ; RNA, Viral
    Language English
    Publishing date 2021-06-23
    Publishing country England
    Document type Journal Article ; Observational Study ; Research Support, Non-U.S. Gov't
    ZDB-ID 2615211-3
    ISSN 2045-2322 ; 2045-2322
    ISSN (online) 2045-2322
    ISSN 2045-2322
    DOI 10.1038/s41598-021-92497-1
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Detection of SARS-CoV-2 RNA in serum is associated with increased mortality risk in hospitalized COVID-19 patients

    Diego A. Rodríguez-Serrano / Emilia Roy-Vallejo / Nelly D. Zurita Cruz / Alexandra Martín Ramírez / Sebastián C. Rodríguez-García / Nuria Arevalillo-Fernández / José María Galván-Román / Leticia Fontán García-Rodrigo / Lorena Vega-Piris / Marta Chicot Llano / David Arribas Méndez / Begoña González de Marcos / Julia Hernando Santos / Ana Sánchez Azofra / Elena Ávalos Pérez-Urria / Pablo Rodriguez-Cortes / Laura Esparcia / Ana Marcos-Jimenez / Santiago Sánchez-Alonso /
    Irene Llorente / Joan Soriano / Carmen Suárez Fernández / Rosario García-Vicuña / Julio Ancochea / Jesús Sanz / Cecilia Muñoz-Calleja / Rafael de la Cámara / Alfonso Canabal Berlanga / Isidoro González-Álvaro / Laura Cardeñoso / the REINMUN-COVID Group

    Scientific Reports, Vol 11, Iss 1, Pp 1-

    2021  Volume 11

    Abstract: ... of patients at risk of poor outcomes is critical. Our objective was to analyse SARS-CoV-2 RNA detection ... admitted for COVID-19. Detection of SARS-CoV-2 RNA in serum (viremia) was performed with samples collected ... for predicting mortality in COVID-19 patients. Viremia is highly reproducible with two different techniques (TFS ...

    Abstract Abstract COVID-19 has overloaded national health services worldwide. Thus, early identification of patients at risk of poor outcomes is critical. Our objective was to analyse SARS-CoV-2 RNA detection in serum as a severity biomarker in COVID-19. Retrospective observational study including 193 patients admitted for COVID-19. Detection of SARS-CoV-2 RNA in serum (viremia) was performed with samples collected at 48–72 h of admission by two techniques from Roche and Thermo Fischer Scientific (TFS). Main outcome variables were mortality and need for ICU admission during hospitalization for COVID-19. Viremia was detected in 50–60% of patients depending on technique. The correlation of Ct in serum between both techniques was good (intraclass correlation coefficient: 0.612; p < 0.001). Patients with viremia were older (p = 0.006), had poorer baseline oxygenation (PaO2/FiO2; p < 0.001), more severe lymphopenia (p < 0.001) and higher LDH (p < 0.001), IL-6 (p = 0.021), C-reactive protein (CRP; p = 0.022) and procalcitonin (p = 0.002) serum levels. We defined "relevant viremia" when detection Ct was < 34 with Roche and < 31 for TFS. These thresholds had 95% sensitivity and 35% specificity. Relevant viremia predicted death during hospitalization (OR 9.2 [3.8–22.6] for Roche, OR 10.3 [3.6–29.3] for TFS; p < 0.001). Cox regression models, adjusted by age, sex and Charlson index, identified increased LDH serum levels and relevant viremia (HR = 9.87 [4.13–23.57] for TFS viremia and HR = 7.09 [3.3–14.82] for Roche viremia) as the best markers to predict mortality. Viremia assessment at admission is the most useful biomarker for predicting mortality in COVID-19 patients. Viremia is highly reproducible with two different techniques (TFS and Roche), has a good consistency with other severity biomarkers for COVID-19 and better predictive accuracy.
    Keywords Medicine ; R ; Science ; Q
    Subject code 610
    Language English
    Publishing date 2021-06-01T00:00:00Z
    Publisher Nature Portfolio
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  3. Article ; Online: Detection of SARS-Cov-2 RNA in serum is associated with increased mortality risk in hospitalized COVID-19 patients.

    Rodriguez Serrano, Diego A. / Roy-Vallejo, Emilia / Zurita Cruz, Nelly D. / Martin Ramirez, Alexandra / Rodriguez-Garcia, Sebastian C. / Arevalillo-Fernandez, Nuria / Galvan-Roman, Jose Maria / Fontan Garcia-Rodrigo, Leticia / Vega Piris, Lorena / Chicot Llano, Marta / Arribas Mendez, David / Gonzalez de Marcos, Begona / Hernando Santos, Julia / Sanchez Azofra, Ana / Avalos Perez-Urria, Elena / Rodriguez-Cortes, Pablo / Esparcia, Laura / Marcos-Jimenez, Ana / Sanchez-Alonso, Santiago /
    Llorente, Irene / Soriano, Joan B. / Suarez Fernandez, Carmen / Garcia-Vicuna, Rosario / Ancochea, Julio / Sanz, Jesus / Munoz-Calleja, Cecilia / de la Camara, Rafael / Canabal Berlanga, Alfonso / Gonzalez-Alvaro, Isidoro / Cardenoso, Laura

    medRxiv

    Abstract: ... including 193 patients admitted for COVID-19. Detection of SARS-CoV-2 RNA in serum (CoVemia) was performed ... of patients at risk of poor outcomes is critical. Our objective was to analyse SARS-CoV-2 RNA detection ... useful biomarker for predicting mortality in COVID-19 patients. CoVemia is highly reproducible with two ...

    Abstract Background COVID-19 has overloaded national health services worldwide. Thus, early identification of patients at risk of poor outcomes is critical. Our objective was to analyse SARS-CoV-2 RNA detection in serum as a severity biomarker in COVID-19. Methods and Findings Retrospective observational study including 193 patients admitted for COVID-19. Detection of SARS-CoV-2 RNA in serum (CoVemia) was performed with samples collected at 48-72 hours of admission by two techniques from Roche and Thermo Fischer Scientific (TFS). Main outcome variables were mortality and need for ICU admission during hospitalization for COVID-19. CoVemia was detected in 50-60% of patients depending on technique. The correlation of Ct in serum between both techniques was good (intraclass correlation coefficient: 0.612; p < 0.001). Patients with CoVemia were older (p = 0.006), had poorer baseline oxygenation (PaO2/FiO2; p < 0.001), more severe lymphopenia (p < 0.001) and higher LDH (p < 0.001), IL-6 (p = 0.021), C-reactive protein (CRP; p = 0.022) and procalcitonin (p = 0.002) serum levels. We defined "relevant CoVemia" when detection Ct was < 34 with Roche and < 31 for TFS. These thresholds had 95% sensitivity and 35 % specificity. Relevant CoVemia predicted death during hospitalization (OR 9.2 [3.8 - 22.6] for Roche, OR 10.3 [3.6 - 29.3] for TFS; p < 0.001). Cox regression models, adjusted by age, sex and Charlson index, identified increased LDH serum levels and relevant CoVemia (HR = 9.87 [4.13-23.57] for TFS viremia and HR = 7.09 [3.3-14.82] for Roche viremia) as the best markers to predict mortality. Conclusions CoVemia assessment at admission is the most useful biomarker for predicting mortality in COVID-19 patients. CoVemia is highly reproducible with two different techniques (TFS and Roche), has a good consistency with other severity biomarkers for COVID-19 and better predictive accuracy.
    Keywords covid19
    Language English
    Publishing date 2021-01-15
    Publisher Cold Spring Harbor Laboratory Press
    Document type Article ; Online
    DOI 10.1101/2021.01.14.21249372
    Database COVID19

    Kategorien

  4. Article ; Online: Detection of SARS-Cov-2 RNA in serum is associated with increased mortality risk in hospitalized COVID-19 patients

    Rodríguez-Serrano, Diego A. / Roy-Vallejo, Emilia / Zurita Cruz, Nelly D. / Ramírez, Alexandra Martín / Rodríguez-García, Sebastián C. / Arevalillo-Fernández, Nuria / Galván-Román, José María / García-Rodrigo, Leticia Fontán / Vega-Piris, Lorena / Llano, Marta Chicot / Méndez, David Arribas / de Marcos, Begoña González / Santos, Julia Hernando / Azofra, Ana Sánchez / Pérez-Urria, Elena Ávalos / Rodriguez-Cortes, Pablo / Esparcia, Laura / Marcos-Jimenez, Ana / Sánchez-Alonso, Santiago /
    Llorente, Irene / Soriano, Joan / Fernández, Carmen Suárez / García-Vicuña, Rosario / Ancochea, Julio / Sanz, Jesús / Muñoz-Calleja, Cecilia / de la Cámara, Rafael / Berlanga, Alfonso Canabal / González-Álvaro, Isidoro / Cardeñoso, Laura

    medRxiv

    Abstract: ... including 193 patients admitted for COVID-19. Detection of SARS-CoV-2 RNA in serum (CoVemia) was performed ... of patients at risk of poor outcomes is critical. Our objective was to analyse SARS-CoV-2 RNA detection ... useful biomarker for predicting mortality in COVID-19 patients. CoVemia is highly reproducible with two ...

    Abstract Background COVID-19 has overloaded national health services worldwide. Thus, early identification of patients at risk of poor outcomes is critical. Our objective was to analyse SARS-CoV-2 RNA detection in serum as a severity biomarker in COVID-19. Methods and Findings Retrospective observational study including 193 patients admitted for COVID-19. Detection of SARS-CoV-2 RNA in serum (CoVemia) was performed with samples collected at 48-72 hours of admission by two techniques from Roche and Thermo Fischer Scientific (TFS). Main outcome variables were mortality and need for ICU admission during hospitalization for COVID-19. CoVemia was detected in 50-60% of patients depending on technique. The correlation of Ct in serum between both techniques was good (intraclass correlation coefficient: 0.612; p < 0.001). Patients with CoVemia were older (p = 0.006), had poorer baseline oxygenation (PaO2/FiO2; p < 0.001), more severe lymphopenia (p < 0.001) and higher LDH (p < 0.001), IL-6 (p = 0.021), C-reactive protein (CRP; p = 0.022) and procalcitonin (p = 0.002) serum levels. We defined "relevant CoVemia" when detection Ct was < 34 with Roche and < 31 for TFS. These thresholds had 95% sensitivity and 35 % specificity. Relevant CoVemia predicted death during hospitalization (OR 9.2 [3.8 - 22.6] for Roche, OR 10.3 [3.6 - 29.3] for TFS; p < 0.001). Cox regression models, adjusted by age, sex and Charlson index, identified increased LDH serum levels and relevant CoVemia (HR = 9.87 [4.13-23.57] for TFS viremia and HR = 7.09 [3.3-14.82] for Roche viremia) as the best markers to predict mortality. Conclusions CoVemia assessment at admission is the most useful biomarker for predicting mortality in COVID-19 patients. CoVemia is highly reproducible with two different techniques (TFS and Roche), has a good consistency with other severity biomarkers for COVID-19 and better predictive accuracy.
    Keywords covid19
    Language English
    Publishing date 2021-01-15
    Publisher Cold Spring Harbor Laboratory Press
    Document type Article ; Online
    DOI 10.1101/2021.01.14.21249372
    Database COVID19

    Kategorien

To top